- Sweden
- /
- Medical Equipment
- /
- OM:ADDV A
ADDvise Group AB (publ) (STO:ADDV A) Shares Could Be 45% Below Their Intrinsic Value Estimate
Key Insights
- The projected fair value for ADDvise Group is kr29.04 based on 2 Stage Free Cash Flow to Equity
- ADDvise Group's kr16.00 share price signals that it might be 45% undervalued
- Industry average discount to fair value of 40% suggests ADDvise Group's peers are currently trading at a lower discount
In this article we are going to estimate the intrinsic value of ADDvise Group AB (publ) (STO:ADDV A) by projecting its future cash flows and then discounting them to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. It may sound complicated, but actually it is quite simple!
We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.
View our latest analysis for ADDvise Group
The Model
We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value:
10-year free cash flow (FCF) estimate
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
Levered FCF (SEK, Millions) | kr221.8m | kr216.1m | kr272.5m | kr424.9m | kr431.7m | kr437.4m | kr442.6m | kr447.7m | kr452.5m | kr457.3m |
Growth Rate Estimate Source | Analyst x2 | Analyst x2 | Analyst x2 | Analyst x1 | Analyst x1 | Est @ 1.31% | Est @ 1.21% | Est @ 1.14% | Est @ 1.09% | Est @ 1.05% |
Present Value (SEK, Millions) Discounted @ 7.7% | kr206 | kr186 | kr218 | kr316 | kr299 | kr281 | kr264 | kr248 | kr233 | kr219 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = kr2.5b
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 1.0%. We discount the terminal cash flows to today's value at a cost of equity of 7.7%.
Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = kr457m× (1 + 1.0%) ÷ (7.7%– 1.0%) = kr6.9b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= kr6.9b÷ ( 1 + 7.7%)10= kr3.3b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is kr5.8b. The last step is to then divide the equity value by the number of shares outstanding. Relative to the current share price of kr16.0, the company appears quite good value at a 45% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.
The Assumptions
We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at ADDvise Group as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.7%, which is based on a levered beta of 1.453. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for ADDvise Group
- Debt is well covered by earnings.
- Earnings declined over the past year.
- Shareholders have been diluted in the past year.
- Annual earnings are forecast to grow faster than the Swedish market.
- Trading below our estimate of fair value by more than 20%.
- Debt is not well covered by operating cash flow.
Looking Ahead:
Whilst important, the DCF calculation is only one of many factors that you need to assess for a company. It's not possible to obtain a foolproof valuation with a DCF model. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. What is the reason for the share price sitting below the intrinsic value? For ADDvise Group, there are three further items you should further research:
- Risks: Case in point, we've spotted 2 warning signs for ADDvise Group you should be aware of, and 1 of them is a bit unpleasant.
- Future Earnings: How does ADDV A's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the OM every day. If you want to find the calculation for other stocks just search here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About OM:ADDV A
ADDvise Group
Supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, South America, Asia, and internationally.
Undervalued moderate.